Published in J Allergy Clin Immunol on May 01, 2003
Predicting worsening asthma control following the common cold. Eur Respir J (2008) 1.70
The role of allergy in severe asthma. Clin Exp Allergy (2012) 1.54
High titers of IgE antibody to dust mite allergen and risk for wheezing among asthmatic children infected with rhinovirus. J Allergy Clin Immunol (2012) 1.38
Comparison of viral load in individuals with and without asthma during infections with rhinovirus. Am J Respir Crit Care Med (2014) 1.23
Host immune responses to rhinovirus: mechanisms in asthma. J Allergy Clin Immunol (2008) 1.14
Asthma exacerbations . 3: Pathogenesis. Thorax (2006) 1.10
IgE expression pattern in lung: relation to systemic IgE and asthma phenotypes. J Allergy Clin Immunol (2007) 1.01
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma. Chest (2014) 1.00
Pathogenesis of rhinovirus infection. Curr Opin Virol (2012) 0.96
CXC chemokines and antimicrobial peptides in rhinovirus-induced experimental asthma exacerbations. Clin Exp Allergy (2014) 0.94
Asthma is associated with multiple alterations in anti-viral innate signalling pathways. PLoS One (2014) 0.90
IgE in the diagnosis and treatment of allergic disease. J Allergy Clin Immunol (2016) 0.86
Increased risk of refractory Mycoplasma pneumoniae pneumonia in children with atopic sensitization and asthma. Korean J Pediatr (2014) 0.85
A rat model of picornavirus-induced airway infection and inflammation. Virol J (2009) 0.84
Immune surveillance by rhinovirus-specific circulating CD4+ and CD8+ T lymphocytes. PLoS One (2015) 0.82
Epidemiology of virus-induced asthma exacerbations: with special reference to the role of human rhinovirus. Front Microbiol (2014) 0.82
Application of nitric oxide measurements in clinical conditions beyond asthma. Eur Clin Respir J (2015) 0.80
Lower respiratory tract infection induced by a genetically modified picornavirus in its natural murine host. PLoS One (2012) 0.80
Rhinovirus and asthma: a storied history of incompatibility. Curr Allergy Asthma Rep (2015) 0.79
Infection with human rhinovirus 16 promotes enhanced IgE responsiveness in basophils of atopic asthmatics. Clin Exp Allergy (2014) 0.78
Association between inflammatory airway disease of horses and exposure to respiratory viruses: a case control study. Multidiscip Respir Med (2015) 0.78
Understanding the Association of Human Rhinovirus with Asthma. Clin Vaccine Immunol (2015) 0.77
Circulating Memory CD4+ T Cells Target Conserved Epitopes of Rhinovirus Capsid Proteins and Respond Rapidly to Experimental Infection in Humans. J Immunol (2016) 0.75
Nasal Levels of Antimicrobial Peptides in Allergic Asthma Patients and Healthy Controls: Differences and Effect of a Short 1,25(OH)2 Vitamin D3 Treatment. PLoS One (2015) 0.75
Increased rhinovirus replication in nasal mucosa cells in allergic subjects is associated with increased ICAM-1 levels and endosomal acidification and is inhibited by L-carbocisteine. Immun Inflamm Dis (2016) 0.75
Deciphering the importance of host and environmental factors that influence the genesis of asthma during childhood. J Infect Dis (2012) 0.75
Avian influenza A (H5N1) infection in humans. N Engl J Med (2005) 12.95
Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med (2008) 10.27
Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med (2010) 9.90
Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet (2004) 8.62
Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med (2008) 6.82
Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis (2009) 6.52
Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol (2004) 5.80
Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis (2002) 4.43
Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol (2004) 4.33
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother (2006) 4.02
Kinetics of influenza A virus infection in humans. J Virol (2006) 3.78
Symptoms of wheeze and persistent cough in the first year of life: associations with indoor allergens, air contaminants, and maternal history of asthma. Am J Epidemiol (2003) 3.51
Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol (2004) 3.49
Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. Am J Epidemiol (2006) 3.48
Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose. J Allergy Clin Immunol (2008) 3.15
Treatment of the common cold with echinacea: a structured review. Clin Infect Dis (2005) 2.91
The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1,3-galactose. J Allergy Clin Immunol (2011) 2.90
Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection. Antimicrob Agents Chemother (2006) 2.69
Imaging the lungs in asthmatic patients by using hyperpolarized helium-3 magnetic resonance: assessment of response to methacholine and exercise challenge. J Allergy Clin Immunol (2003) 2.59
Expression and activity of pH-regulatory glutaminase in the human airway epithelium. Am J Respir Crit Care Med (2002) 2.54
Influenza in the acute hospital setting. Lancet Infect Dis (2002) 2.53
How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count. Lancet (2009) 2.44
Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J Infect Dis (2006) 2.43
Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay. Antiviral Res (2002) 2.22
Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors. Antimicrob Agents Chemother (2005) 2.17
Correlation of diffusion tensor tractography and intraoperative macrostimulation during deep brain stimulation for Parkinson disease. J Neurosurg (2014) 2.11
Picornavirus infections in children diagnosed by RT-PCR during longitudinal surveillance with weekly sampling: Association with symptomatic illness and effect of season. J Med Virol (2006) 2.06
Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg (2004) 2.01
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol (2006) 2.00
Dust mite, cockroach, cat, and dog allergen concentrations in homes of asthmatic children in the northeastern United States: impact of socioeconomic factors and population density. Environ Health Perspect (2002) 1.99
Atopy, asthma, and antibodies to Ascaris among rural and urban children in Kenya. J Pediatr (2002) 1.96
Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol (2004) 1.94
Quantitative measurement of IgE antibodies to purified allergens using streptavidin linked to a high-capacity solid phase. J Allergy Clin Immunol (2005) 1.87
WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect Dis (2007) 1.85
"Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events. J Infect Dis (2009) 1.77
Asthma outcomes: exacerbations. J Allergy Clin Immunol (2012) 1.76
Human metapneumovirus infection in children hospitalized for wheezing. J Allergy Clin Immunol (2005) 1.75
Prospective observational study of chronic rhinosinusitis: environmental triggers and antibiotic implications. Clin Infect Dis (2011) 1.72
Contribution of dust mite and cat specific IgE to total IgE: relevance to asthma prevalence. J Allergy Clin Immunol (2007) 1.70
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis (2011) 1.66
Pro: The evidence for a causal role of dust mites in asthma. Am J Respir Crit Care Med (2009) 1.65
Sensitization to mouse allergen and asthma and asthma morbidity among women in Boston. J Allergy Clin Immunol (2007) 1.60
The variability of regional airflow obstruction within the lungs of patients with asthma: assessment with hyperpolarized helium-3 magnetic resonance imaging. J Allergy Clin Immunol (2007) 1.58
Treatment of naturally acquired common colds with zinc: a structured review. Clin Infect Dis (2007) 1.57
Risk of childhood asthma in relation to the timing of early child care exposures. J Pediatr (2009) 1.56
Variation in total and specific IgE: effects of ethnicity and socioeconomic status. J Allergy Clin Immunol (2005) 1.56
Drug resistance and influenza pandemics. Lancet (2002) 1.55
Impact of the Accreditation Council for Graduate Medical Education work-hour regulations on neurosurgical resident education and productivity. J Neurosurg (2009) 1.53
Exposure to dust mite allergen and endotoxin in early life and asthma and atopy in childhood. J Allergy Clin Immunol (2007) 1.53
Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial. JAMA (2007) 1.52
Influenza A (H5N1): will it be the next pandemic influenza? Are we ready? Ann Intern Med (2005) 1.52
The role of indoor allergen sensitization and exposure in causing morbidity in women with asthma. Am J Respir Crit Care Med (2002) 1.50
Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia. Clin Infect Dis (2003) 1.48
Open source clinical science for emerging infections. Lancet Infect Dis (2014) 1.47
Comparative activities of oseltamivir and A-322278 in immunocompetent and immunocompromised murine models of influenza virus infection. J Infect Dis (2006) 1.46
Assessment of hemagglutinin sequence heterogeneity during influenza virus transmission in families. J Infect Dis (2002) 1.42
Effect of cat and dog ownership on sensitization and development of asthma among preteenage children. Am J Respir Crit Care Med (2002) 1.42
Physical activity and exercise in asthma: relevance to etiology and treatment. J Allergy Clin Immunol (2005) 1.41
Sinus computed tomography scan and markers of inflammation in vocal cord dysfunction and asthma. Ann Allergy Asthma Immunol (2003) 1.40
Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007. Antivir Ther (2009) 1.39
Viral infections in immunocompromised patients: what's new with respiratory viruses? Curr Opin Infect Dis (2002) 1.38
High titers of IgE antibody to dust mite allergen and risk for wheezing among asthmatic children infected with rhinovirus. J Allergy Clin Immunol (2012) 1.38
Specific IgE and IgG antibody-binding patterns to recombinant cockroach allergens. J Allergy Clin Immunol (2005) 1.33
Emerging influenza antiviral resistance threats. J Infect Dis (2011) 1.32
American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxis. J Allergy Clin Immunol (2007) 1.32
Cat and dust mite sensitivity and tolerance in relation to wheezing among children raised with high exposure to both allergens. J Allergy Clin Immunol (2005) 1.31
Rhinovirus and coronavirus infection-associated hospitalizations among older adults. J Infect Dis (2002) 1.31
Relationship between red meat allergy and sensitization to gelatin and galactose-α-1,3-galactose. J Allergy Clin Immunol (2012) 1.31
Viral respiratory tract infections and asthma: the course ahead. J Allergy Clin Immunol (2010) 1.29
A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen. J Immunol (2004) 1.28
Anaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinant. J Allergy Clin Immunol (2009) 1.28
Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob Agents Chemother (2003) 1.27
Predictors of cord blood IgE levels in children at risk for asthma and atopy. J Allergy Clin Immunol (2006) 1.27
Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment. Antivir Ther (2005) 1.24
Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age. Vaccine (2008) 1.23
Allergenicity of carbohydrates and their role in anaphylactic events. Curr Allergy Asthma Rep (2010) 1.23
Comparison of viral load in individuals with and without asthma during infections with rhinovirus. Am J Respir Crit Care Med (2014) 1.23
Symptom profile of common colds in school-aged children. Pediatr Infect Dis J (2008) 1.19
Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J Infect (2013) 1.19
Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza. Antivir Ther (2003) 1.18
The Southeast Asian Influenza Clinical Research Network: development and challenges for a new multilateral research endeavor. Antiviral Res (2007) 1.17
Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses. Antimicrob Agents Chemother (2005) 1.16
Dispersal of Staphylococcus aureus into the air associated with a rhinovirus infection. Infect Control Hosp Epidemiol (2005) 1.15
How do we avoid developing allergy: modifications of the TH2 response from a B-cell perspective. J Allergy Clin Immunol (2004) 1.14
Airborne endotoxin in homes with domestic animals: implications for cat-specific tolerance. J Allergy Clin Immunol (2005) 1.14
Galactose-α-1,3-galactose-specific IgE is associated with anaphylaxis but not asthma. Am J Respir Crit Care Med (2012) 1.12
End points for testing influenza antiviral treatments for patients at high risk of severe and life-threatening disease. J Infect Dis (2010) 1.11